Value investing is always a very popular strategy, and for good reason. After all, who doesn’t want to find stocks that have low PEs, solid outlooks, and decent dividends?
Fortunately for investors looking for this combination, we have identified a strong candidate which may be an impressive value; VEON Ltd. (VEON - Free Report) .
VEON in Focus
VEON may be an interesting play thanks to its forward PE of 18.5 its P/S ratio of 0.5, and its decent dividend yield of 6.6%. These factors suggest that VEON Ltd. is a pretty good value pick, as investors have to pay a relatively low level for each dollar of earnings, and that VEON has decent revenue metrics to back up its earnings.
But before you think that VEON is just a pure value play, it is important to note that it has been seeing solid activity on the earnings estimate front as well. For current year earnings, the consensus has significantly gone up in the past 30 days, thanks to one upward revision in the past one month.
This estimate strength is actually enough to push VEON to a Zacks Rank #2 (Buy), suggesting it is poised to outperform. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
So really, VEON Ltd. is looking great from a number of angles thanks to its PE below 20, a P/S ratio below one, and a strong Zacks Rank, meaning that this company could be a great choice for value investors at this time.
5 Companies Verge on Apple-Like Run
Did you miss Apple's 9X stock explosion after they launched their iPhone in 2007? Now 2018 looks to be a pivotal year to get in on another emerging technology expected to rock the market. Demand could soar from almost nothing to $42 billion by 2025. Reports suggest it could save 10 million lives per decade which could in turn save $200 billion in U.S. healthcare costs. A bonus Zacks Special Report names this breakthrough and the 5 best stocks to exploit it. Like Apple in 2007, these companies are already strong and coiling for potential mega-gains.
Click to see them right now >>